November 28, 2014 10:05 AM ET

Healthcare Equipment and Supplies

Company Overview of Clarimedix, Inc.

Executive Profile

P. Murali Doraiswamy M.D.

Member of Alzheimer’S Disease Scientific Advisory Board, Clarimedix, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 6 different industries.

See Board Relationships
----

Background

Dr. P. Murali Doraiswamy, MD serves as Chief of the Division of Biological Psychiatry in the Department of Psychiatry at Duke University Medical Center. Dr. Doraiswamy serves as the Head of the Biological Psychiatry division at Duke University. He serves as a Consultant to the FDA, WHO, NIA and leads pharmaceutical companies. He serves as the Director of Psychiatry Clinical trials at Duke's psychiatry department for 10 years, Dr. Doraiswamy served as the Lead Physician ...

Corporate Headquarters

12635 East Montview Boulevard
Aurora, Colorado 80010

United States

Phone: --
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD 1987
University of Madras

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Clarimedix, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.